Previsioni sul mercato degli oppioidi nell\'Asia Pacifica fino al 2030 - Analisi regionale - per prodotto (oppioide a rilascio immediato a breve durata d\'azione e oppioide a rilascio prolungato a lunga durata d\'azione), applicazione (gestione del dolore, anestesia, soppressione della diarrea, soppressione della tosse, disintossicazione e altri), via di somministrazione (orale, iniettabile e cerotto transdermico) e canale di distribuzione (farmacie ospedaliere e farmacie al dettaglio)
L\'aumento dell\'incidenza del dolore cronico aumenta il mercato degli oppioidi dell\'Asia Pacifica
Malattie croniche come malattie cardiovascolari, cancro, malattie muscoloscheletriche e malattie neurovascolari influenzano in modo critico la salute di una persona abbassando l\'immunità. Inoltre, molti pazienti che soffrono di queste condizioni soffrono di dolore cronico. Le malattie sopra menzionate sono più comuni negli adulti e nella popolazione geriatrica. Tuttavia, i casi di queste malattie stanno aumentando notevolmente anche tra i bambini. Il dolore cronico è comune anche tra sportivi, atleti e individui che vivono con infortuni passati. Secondo uno studio pubblicato nel NCBI (ovvero, National Center for Biotechnology Information), il 20% degli adulti soffre di dolore in tutto il mondo e il 10% riceve una nuova diagnosi di dolore cronico ogni anno. Mentre il dolore colpisce tutte le popolazioni, indipendentemente da sesso, razza/etnia, reddito, età o geografia, non è distribuito equamente nel mondo. Gli oppioidi da prescrizione, tra cui idrocodone, ossicodone e morfina, sono potenti farmaci antidolorifici utilizzati per trattare il dolore causato da lesioni, interventi chirurgici e condizioni di salute come cancro e artrite.
L\'aumento delle pratiche di prescrizione di oppioidi può essere attribuito ai programmi di rimborso assicurativo che incentivano gli oppioidi rispetto ai trattamenti alternativi del dolore, alle strutture dei costi che incoraggiano cure più efficienti e alle valutazioni che combinano la soddisfazione del paziente con un\'efficace gestione del dolore. Pertanto, a causa del vantaggio degli oppioidi nella gestione del dolore, la domanda è in aumento tra i pazienti con malattie croniche.
Panoramica del mercato degli oppioidi dell\'Asia Pacifica
Si stima che la crescente popolazione geriatrica in Cina che soffre di malattie terminali aumenterà significativamente la domanda di oppioidi. Secondo l\'Organizzazione mondiale della sanità (OMS), il paese ha una delle popolazioni anziane in più rapida crescita. Secondo la stessa fonte, 254 milioni di persone avevano 60 anni e più nel 2019 e 176 milioni di persone avevano 65 anni e più. Inoltre, si prevede che circa il 28% della popolazione (402 milioni di persone) in Cina avrà 60 anni e più entro il 2040 a causa dell\'aumento dell\'aspettativa di vita e del calo dei tassi di natalità. Le popolazioni geriatriche hanno maggiori probabilità di soffrire di condizioni di salute croniche associate al dolore, come artrite, mal di schiena, cancro, ecc. In tali casi, gli oppioidi vengono utilizzati per gestire il dolore cronico negli anziani, il che influenza significativamente la crescita del mercato degli oppioidi dell\'Asia Pacifica in Cina. In Cina, il numero di nuovi pazienti oncologici che soffrono di dolore patologico grave è aumentato significativamente. Secondo uno studio, \"Impatto della formazione medica continua per i medici sulla qualità del trattamento del dolore oncologico in Cina\", pubblicato nel 2020, il governo cinese incoraggia l\'uso di analgesici oppioidi per il trattamento del dolore oncologico da moderato a grave, ampiamente disponibili negli ospedali terziari e secondari in tutto il paese. Poiché gli oppioidi sono una parte importante di una scala analgesica a tre gradini e sono raccomandati per alleviare il dolore oncologico moderato e grave, aumentare la consapevolezza riguardo a tali condizioni mediche e al trattamento associato può migliorare il piano di trattamento per il dolore oncologico.
Entrate e previsioni del mercato degli oppioidi dell\'Asia Pacifico fino al 2030 (milioni di $ USA)
Segmentazione del mercato degli oppioidi dell\'Asia Pacifico
Il mercato degli oppioidi dell\'Asia Pacifico è suddiviso in prodotto, applicazione, via di somministrazione, canale di distribuzione e paese.
In base al prodotto, il mercato degli oppioidi dell\'Asia Pacifico è segmentato in oppioidi a rilascio immediato a breve durata d\'azione e oppioidi a rilascio prolungato a lunga durata d\'azione. Il segmento degli oppioidi a rilascio immediato e breve durata d\'azione ha detenuto una quota di mercato maggiore nel 2022. L\'oppioide a rilascio immediato e breve durata d\'azione è ulteriormente suddiviso in ossicodone, idrocodone, tramadolo, codina, propossifene e altri. L\'oppioide a rilascio prolungato e lunga durata d\'azione è ulteriormente suddiviso in ossicodone, fentanil, morfina, metadone e altri.
In termini di applicazione, il mercato degli oppioidi dell\'Asia Pacifica è suddiviso in gestione del dolore, anestesia, soppressione della diarrea, soppressione della tosse, de-dipendenza e altri. Il segmento della gestione del dolore ha detenuto la quota di mercato maggiore nel 2022.
In base alla via di somministrazione, il mercato degli oppioidi dell\'Asia Pacifica è suddiviso in cerotto orale, iniettabile e transdermico. Il segmento orale ha detenuto la quota di mercato maggiore nel 2022.
In base al canale di distribuzione, il mercato degli oppioidi dell\'Asia Pacifica è suddiviso in farmacie ospedaliere e farmacie al dettaglio. Il segmento delle farmacie ospedaliere ha detenuto una quota di mercato maggiore nel 2022.
Per paese, il mercato degli oppioidi dell\'Asia Pacifica è segmentato in Cina, Giappone, India, Corea del Sud, Australia e resto dell\'Asia Pacifica. La Cina ha dominato la quota di mercato degli oppioidi dell\'Asia Pacifica nel 2022.
Endo International plc, Mallinckrodt Plc, Neuraxpharm Pharmaceuticals SL, Mayne Pharma Group Ltd, Rusan Pharma Ltd e Teva Pharmaceutical Industries Ltd sono alcune delle aziende leader che operano nel mercato degli oppioidi dell\'Asia Pacifica.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - Asia Pacific Analysis
5.1 Asia Pacific Opioids Market Overview
5.2 Asia Pacific Opioids Market Revenue (US$ Million), 2020-2030
5.3 Asia Pacific Opioids Market Forecast Analysis
6. Asia Pacific Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. Asia Pacific Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Opioids Market - Country Analysis
10.1 Asia Pacific
10.1.1 Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.1.1 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Country
10.1.1.2 China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 China: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.2.2 China: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.2.3 China: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.2.4 China: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.2.5 China: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.2.6 China: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.3 Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Japan: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.3.2 Japan: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.3.3 Japan: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.3.4 Japan: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.3.5 Japan: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.3.6 Japan: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.4 India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 India: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.4.2 India: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.4.3 India: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.4.4 India: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.4.5 India: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.4.6 India: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.5 South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 South Korea: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.5.2 South Korea: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.5.3 South Korea: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.5.4 South Korea: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.5.5 South Korea: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.5.6 South Korea: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.6 Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Australia: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.6.2 Australia: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.6.3 Australia: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.6.4 Australia: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.6.5 Australia: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.6.6 Australia: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.7 Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.7.1 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.7.4 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.7.5 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.7.6 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Mayne Pharma Group Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rusan Pharma Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
?
List of Tables
Table 1. Asia Pacific Opioids Market Segmentation
Table 2. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. Asia Pacific: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 13. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 15. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 19. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 21. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 25. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 29. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 30. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 31. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 32. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 33. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 34. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 35. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 36. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 37. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 38. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 39. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 40. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 41. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 42. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 43. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 44. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 45. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 46. Recent Organic Growth Strategies in Opioids Market
Table 47. Recent Inorganic Growth Strategies in the Opioids Market
Table 48. Glossary of Terms, Opioids Market
?
List of Figures
Figure 1. Asia Pacific Opioids Market Segmentation, by Country
Figure 2. Asia Pacific Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. Asia Pacific Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific: Opioids Market, by Key Countries - Revenue (2022) (US$ Million)
Figure 23. Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Growth Strategies in Opioids Market
- Endo International plc
- Mallinckrodt Plc
- Neuraxpharm Pharmaceuticals SL
- Mayne Pharma Group Ltd
- Rusan Pharma Ltd
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific opioids market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific opioids market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific opioids market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.